Introduction 67
The lung plays a critical role in both gas exchange and mucosal immunity, and its anatomy 68 serves these functions through (1) the airways that lead air to the respiratory unit, provide 69 mucociliary clearance, and form a barrier against inhaled particles and pathogens; and (2) 70 the alveoli, distal saccular structures where gas exchange occurs. Acute and chronic 71 disorders of the lung are a major cause of morbidity and mortality worldwide 1 . To better 72 understand pathogenesis of lung disease, it is imperative to characterise the cell types of 73 the lung and understand their interactions in health 2,3 and disease. The recent identification 74 of the ionocyte as a novel airway epithelial cell-type 4,5 underscores our incomplete 75 understanding of the cellular landscape of the lung, which limits our insight into the 76 mechanisms of respiratory disease, and hence our ability to design therapies for most lung 77 disorders.
79
We set out to profile lung-resident structural and inflammatory cells and their interactions by 80 analysing healthy human respiratory tissue from four sources: nasal brushes, endobronchial 81 biopsies and brushes from living donors, and tissue samples from lung resections and 82 transplant donor lungs. Our single cell analysis identifies differences in the proportions and 83 transcriptional phenotype of structural and inflammatory cells between upper and lower 84 airways and lung parenchyma. Using an unbiased approach to identify tissue-resident CD4 85
T cells in airway wall, we identify a novel tissue migratory CD4 T cell (TMC) that harbours 86 features of both circulating memory cells and of tissue resident memory cells (TRM) CD4 T 87 cells. We demonstrate that many disease-associated genes have highly cell type-specific 88 expression patterns. This holds true for both rare disease-associated genes, such as CFTR 89 mutated in cystic fibrosis, as well as genes associated with a common disease such as 90 asthma.
92
In addition, we evaluate the altered cellular landscape of the airway wall in chronic 93 inflammatory disease using bronchial biopsies from asthma patients. We identify a novel 94 epithelial cell state highly enriched in asthma, the mucous ciliated cell. Mucous ciliated cells 95 represent a transitioning state of ciliated cells with molecular features of mucus production, 96
and contribute to mucous cell hyperplasia in this chronic disease. Other changes associated 97 with asthma include increased numbers of goblet cells, intraepithelial mast cells and 98 pathogenic effector Th2 cells in airway wall tissue. We examine intercellular communications 99 occurring in the healthy and asthmatic airway wall, and reveal a remarkable loss of epithelial 100 communication and a concomitant increase in Th2 cell interactions. The newly identified 101 TMC subset interacts with epithelial cells, fibroblasts and airway smooth muscle cells in 102 asthma. Collectively, these data generate novel insights into epithelial cell changes and 103 altered communication patterns between immune and structural cells of the airways, that 104 underlie asthmatic airway inflammation. 105
A human lung cell census identifies macro-anatomical patterns of epithelial cell 106
states across the human the respiratory tree 107
The cellular landscape along the 23 generations of the airways in human lung is expected 108 to differ both in terms of relative frequencies of cell types and their molecular phenotype 6 . 109
We used 10x Genomics Chromium droplet single-cell RNA sequencing (scRNA-Seq) to 110 profile a total of 36,931 single cells from upper and lower airways, and lung parenchyma 111 ( Figure 1A , B). We profiled nasal brushes, and (bronchoscopic) brushes and biopsies from 112 airway wall (third to sixth generation) from healthy volunteers. populations (epithelial and non-epithelial) (Extended Figure 2) . Using MatchSCore 8 to 124
quantify the overlap between cell type marker signatures between the two datasets revealed 125 an extensive degree of overlap in cell type identities (Extended Figure 2) . In our analysis 126 below, we first concentrate on epithelial cells (Figure 1 ), and then focus on the stromal and 127 immune compartments (Figure 2 ). 128 129
In the epithelial lineage, we identified a total of at least 10 cell types across the upper and 130 lower airways and lung parenchyma ( Figure 1C , Extended Data Figure 1 ). We detected 131 multiple basal, club, ciliated and goblet cell states, as well as type-1 (T1) and type-2 (T2) 132 alveolar cells, and the recently described ionocyte 4,5 (Extended Figure 3) . Both goblet and 133 ciliated cells were present in the nasal epithelium ( Figure 1D ). Figure 4) . Tuft cell marker genes did not identify 144 a unique cell population. Ionocytes were found in lower airways, and at very low frequency 145 in upper airways, but were completely absent from the parenchyma. Comparison of the cell 146 populations identified using the two different bronchoscopic sampling methods (brush 147 versus biopsy) in lower airways showed that basal cells were captured most effectively in 148 biopsies, while apical epithelial cells, such as ciliated and club cells were relatively 149 overrepresented in the bronchial brushings ( Figure 1D ). 150 151
Our dataset allowed us to identify two discrete cell states in basal, goblet and ciliated 152 epithelial cells. Some of these cell phenotypes were restricted to specific anatomical 153 locations along the respiratory tract. Basal cells were present in both upper and lower 154 airways, although at relatively low frequency in upper airways ( Figure 1E ). The two basal 155 cell states corresponded to differentiation stages, with the less mature Basal 1 cell state 156 expressing higher levels of TP63 and NPPC in comparison to Basal 2 cells ( Figure 1F and 157 extended data 1), which were more abundant in bronchial brushes, suggesting a more apical 158 localization for these more differentiated basal cells ( Figure 1D ). Goblet 1 and 2 cells were 159 both characterized by high expression of CEACAM5, S100A4, MUC5AC and lack of MUC5B 160 ( Figure 1F and Extended Figures 1 and 4) . Goblet 1 cells specifically express KRT4 and 161 CD36 ( Figure 1G and Extended Figure 4 ). Genes involved with immune function, such as 162 IDO1, NOS2, IL19, CSF3 (Granulocyte-colony stimulating factor) and CXCL10 are 163 expressed at high levels in Goblet 2 cells ( Figure 1G and Extended Figure 4 ). These 164 molecules enriched in Goblet 2 cells are involved in recruitment of neutrophils, monocytes, 165 dendritic cells and T cells 9 . Both goblet cells states are present in upper airway epithelium, 166
with Goblet 1 cells being more frequent. In contrast, the Goblet 2 cell state was also present 167 in lower airways, albeit at low abundance ( Figure 1E Figure 1H and Extended Figure 4) . Interestingly, comparison of the location-177 specific differences between ciliated and goblet cells identified a transcriptional signature 178 specific for the upper airways present in both epithelial cell types (Extended Figure 4B) . 179 180
Next, we assessed the contribution of specific epithelial cell types to Mendelian disease. 181
Cell-type specific expression patterns of genes associated with Mendelian disorders (based 182 on the Online Mendelian Inheritance in Man, OMIM database) confirm ionocytes as 183 particularly high expressers of the CFTR gene, mutated in cystic fibrosis ( Figure 1I ). These 184 cells also express SCNN1B, mutations of which can cause bronchiectasis, another feature 185 of cystic fibrosis, suggesting a potential key pathological role for ionocytes in both 186 bronchiectasis and cystic fibrosis. In addition, expression of SERPINA1 ( Figure 1I ) was 187 found to be enriched in type-2 alveolar epithelial cells, underscoring their role in alpha-1-188 antitrypsin deficiency 13 . 189 This suggests an isotype-driven micro-anatomical segregation of B cells in the airways 217 (Extended Figure 5F ). 218
Molecular features of mucous cell metaplasia in asthma 219
To characterize the changes in the cellular landscape of airway wall in a chronic 220 inflammatory condition, we also analysed bronchial biopsies from six volunteers with 221 persistent, childhood-onset asthma ( Figure 3A ). Asthma is a complex disease 17 Figure 6A and B). 226 227
High-resolution clustering of the EPCAM + clusters identifies 10 sub clusters representing the 228 6 epithelial cell types observed in healthy airway wall ( Figure 1C ), as well as two additional 229 basal cell states: a mucous ciliated cell state, and serous cells from the submucosal glands 230 ( Figure 3B ). In addition to the two basal cell states observed in healthy airway wall ( Figure  231 1C), the basal cell states in asthma include activated and cycling cell states ( Figure 3B ).
232
Activated basal cells closely resemble Basal 1 cells in their transcriptional phenotype, but 233 also express proinflammatory genes such as POSTN ( Figure 3D ). Cycling basal cells are 234 characterized by expression of canonical marker genes of proliferating cells (MKI67 and 235 TOP2A) ( Figure 3D ), and this is the only cluster of airway epithelial cells expressing the 236 squamous cell marker KRT13 (Extended Figure 6 ).
238
We observe mucous cell hyperplasia in asthma, with a strong increase in goblet cell 239 numbers ( Figure 3C ), which are very rare in healthy airway wall biopsies ( Figure 1E ).
240
Moreover, the goblet cell transcriptional phenotype is altered in asthma, with strongly 241 increased expression of MUC5AC and SPDEF, as well as proinflammatory and remodelling 242 genes including NOS2, CEACAM5 and CST1 ( Figure 3D ). In addition, we identify a strong 243 increase in mucous ciliated cells, a novel cell state that has remarkable transcriptional 244 resemblance to ciliated cells, whilst co-expressing a number of mucous genes, including 245 MUC5AC, SERPINB2/3 and CEACAM5 ( Figure 3D , Extended Figure 6 ). Mucous ciliated 246 cells lack expression of the transcription factor SPDEF (in contrast to club and goblet cells), 247 while maintaining FOXJ1 expression, underscoring their ciliated cell origin (Extended Figure  248 7). 249 250
To further dissect the inferred differentiation trajectories in healthy and asthmatic airway wall 251 epithelial cells, we performed pseudotime analysis 23 . This reveals a trajectory starting with 252 basal cell subsets, bifurcating into either a secretory lineage (mainly club cells) or a ciliated 253 lineage in healthy airway wall ( Figure 3E ). In asthma, the secretory lineage is a mix of club 254 and goblet cells, while the mucous ciliated cell state overlaps with the ciliated differentiation 255 trajectory ( Figure 3E ,F). 256 257
Next, we further analysed the transcriptional profiles of the two mucous cell states we 258 observe specifically in asthma: the mucous ciliated cells and the goblet cells. Figure 7) . In club cells, expression of NOTCH target genes 25,26 is 265 not different between asthma and healthy-derived cells. In contrast, in goblet cells, the 266 NOTCH target gene signature is retained only in cells from healthy airway wall, and is lost 267 in asthma. 268 269
As in goblet cells, mucous ciliated cells also lack expression of Notch target genes in asthma 270 (Extended Figure 7) . Hence, we postulate that mucous ciliated cells represent a transition 271 cell state in the ciliated lineage -induced by IL4/IL13 signalling -leading to a mucous cell 272 phenotype which contributes to mucous cell metaplasia in asthma 24 . Similar to goblet cells, 273 mucous ciliated cells express asthma genes such as CST1 28 and POSTN ( Figure 3D ), 274
indicating that these cells also contribute to airway inflammation and remodelling. 275 276
Integrating the asthma GWAS genes with our epithelial single cell transcriptomic data 277 reveals a broad contribution of the airway epithelial cell types to asthma susceptibility ( We observed an increase in the number of B cells in the asthmatic airways ( Figure 4C ) and 310 these cells have a plasma cell phenotype, with high JCHAIN expression ( Figure 4D ). The 311 increase in B cell numbers was mostly of IgM+ cells (IGHM) ( Figure 4E ). IgM levels in 312 asthma BALF samples have been reported to be either increased 34 or unchanged 35 , 313
suggesting cohort dependent variability. IgM-producing B cells in the healthy airways were 314 mostly present in the airway lumen (Extended Figure 5F ). However, as we did not analyse 315 brush samples from asthmatic patients, we cannot precisely pinpoint whether the increase 316 in IgM+ B cells takes place in the intraepithelial region or in the lumen, as both regions are 317 present in biopsy samples. 318
319
Asthma GWAS genes show highly cell-type restricted expression ( Figure 4F ). When 320 excluding the widely expressed HLA genes from the analysis, fibroblasts and T cells express 321 the highest number of asthma GWAS genes ( Figure 4F ), which are mostly upregulated in 322 asthma ( Figure 4F ). GATA3 expression is restricted to T cells ( Figure 4F ), and increased in 323 T cells from asthma patients ( Figure 4F and G). We detected increased expression of CD4 324 (but not CD8a) in the T cell cluster, suggesting an increase in Th2 CD4 T cells ( Figure 4G ). 325
Therefore, we next proceed to investigate the CD4 T cell compartment in depth. 326
Pathogenic effector Th2 cells are enriched in asthmatic airways 327
In line with the increase in GATA3 and CD4 expression mentioned above, CD4 Th2 cells 328 are known to be key drivers of asthma 17, 36 . To assess the presence of Th2 effector cells in 329 the airways of asthma patients ( Figure 4G ), we single cell sorted CD4 T cells followed by 330
plate-based SmartSeq2 analysis for in depth transcriptional phenotyping of the T helper cell 331 compartment (see Methods for details). We analysed cells from both peripheral blood and 332 airway wall biopsies ( Figure 5A ) from a larger cohort of asthma patients and healthy controls 333 ( Figure 5B ). Unbiased clustering reveals six major populations of CD4 T cells (Figure 5C  334 and Extended Figure 11) . At this coarse level of analysis, none of these six clusters was 335 specifically enriched in asthma patients ( Figure 5D ). 336 337
Comparative analysis of CD4 T cells isolated from paired blood and lung samples allows us 338
to differentiate between tissue-resident T cells and circulating T cells in an unbiased way, 339
by subtracting the populations shared with blood from the populations specific to the 340 biopsies ( Figure 5E ). Using this approach, we identified two subsets highly enriched in the 341 lungs: the classical Tissue Resident Memory (TRM) CD4 T cells, and a novel subset we 342 named Tissue Migratory CD4 T cell (TMC) ( Figure 5E ). Naive/central memory (CM), effector 343 memory (EM), and EMRA cells, as well as a mixed Treg/Th2 cluster, are either enriched in 344 blood or present in both blood and airways ( Figure 5E ). 345 346
To better understand the two distinct lung-restricted CD4 T cell subsets, we performed 347 differential expression analysis between TRM and TMC cells ( Figure 5F ). Several 348 transcription factors highly expressed in circulating cells are enriched in TMC cells, such as 349 LEF1, SATB1 and KLF3, while ZEB2 is specific for TRM cells. TMC cells expressed the 350 tissue egression markers S1PR1, CCR7 and SELL (CD62L) and lacked expression of the 351 canonical TRM marker ITGAE (CD103) ( Figure 5F ). As low numbers of TMC cells were 352 present in peripheral blood CD4 T cells ( Figure 5E ), these data suggest that these cells have 353 the potential to transit between lung and blood, a hypothesis supported by pseudotime 354 trajectory analysis of the CD4 T cell subsets (Extended Figure 12) Figure 5G , 376
Extended Figure 13 ). Cytokine-producing cells were mostly retrieved from the biopsies, with 377 only very few present in blood (Extended Figure 14) . 378 379
In terms of absolute numbers, Th2 cells were very rare and found both in healthy and 380 asthmatic patients, although numbers of Th2 cells were significantly increased in the airway 381 wall in the asthma patients, with no detected difference in the relative proportions of the 382 other subsets ( Figure 5H ). In addition to the signature cytokines and the transcription factor 383 GATA3 (Extended Figure 13) 
395
(www.cellphonedb.org), to chart combinatorial cell-specific expression patterns of genes 396 encoding receptor/ligand pairs. We aim to identify potential cell-cell interactions in the airway 397 wall, and define their changes in asthma. Whilst most interactions are unchanged, some 398 were specific to the diseased or healthy state (Full list in Extended 6). 399 400
In healthy controls, the cell-cell interaction landscape of the airway wall was dominated by 401 lung structural cells (mainly mesenchymal and epithelial cell types) communicating with 402 other lung structural cells and with tissue-resident T cells, both the classical TRM and the 403 newly identified TMC subsets ( Figure 6A ,B, left panels). In the asthmatic airway wall, the 404 number of predicted interactions between epithelial and mesenchymal cells was strongly 405 reduced. Instead, the cell-cell communication landscape in asthmatic airway wall is 406 dominated by Th2 cells that were found to have increased interactions with other immune 407 cells, including antigen-presenting cells, and also with epithelial cells (( Figure 6A ,B, right 408 panels). The most striking increase in interactions is with mesenchymal cells, both 409 fibroblasts and smooth muscle cells ( Figure 6A and B, right panels). 410 411
Analysis of the predicted cell-cell interactions between structural cells in healthy airway wall 412 revealed a wealth of growth factor-signalling pathways including the FGF, GFR, IGF, TGF, 413 PDGF and VEGF pathways, most of which were lost in the asthmatic samples ( Figure 6C ). The epithelial cell changes in airway wall in asthma are surprisingly different to those 475 recently described in patients with in chronic rhinosinusitis with polyps 27 . In this chronic 476 inflammatory disease of the upper airways caused by exaggerated type-2 immunity, an 477 IL4/IL13-driven gene transcription profile was mainly observed in basal epithelial cells, which 478 were found to be arrested in differentiation and highly increased in numbers 27 . Using the 479 same IL4/IL13-driven gene module, we find some expression thereof in basal cells, but in 480 asthma this does not result in significant changes in basal cell numbers. Instead, we observe 481 an increased number of goblet cells, as well as of mucous ciliated cells, both of which show 482 evidence of marked expression of the IL4/IL13-driven gene signature (extended data Figure  483 7). Hence, while there is some overlap in the cellular mechanisms underlying rhinosinusitis 484 with polyps and asthma, the resultant changes in cellular states and their frequencies in 485 airway wall differ considerably between the epithelia of the upper versus the lower airways.
486
In contrast, the changes in the eicosanoid pathway observed in chronic type-2 inflammation 487 of the upper 27 and lower (extended data Figure 10) and a positive provocation test (i.e. PC20 methacholine ≤8mg/ml with 2-minute protocol). For 790 the non-asthmatic controls, the following criteria were essential for inclusion: absent history 791 of asthma, no use of asthma-related medication, a negative provocation test (i.e. PC20 792 methacholine >8 mg/ml and adenosine 5'-monophosphate >320 mg/ml with 2-minute 793 protocol), no pulmonary obstruction (i.e. FEV1/FVC ≥70%) and absence of lung function 794 impairment (i.e. FEV1 ≥80% predicted).
795
Asthmatics stopped inhaled corticosteroid use 6 weeks prior to all tests. All subjects were 796
clinically characterised with pulmonary function and provocation tests, blood samples were 797 drawn, and finally subjects underwent a bronchoscopy under sedation. If a subject 798 developed upper respiratory symptoms, bronchoscopy was postponed for ≥6 weeks.
799
Fibreoptic bronchoscopy was performed using a standardised protocol during conscious 800 sedation [1] . Six macroscopically adequate endobronchial biopsies were collected for this 801 study, located between the 3 rd and 6 th generation of the right lower and middle lobe.
802
Extracted biopsies were processed directly thereafter, with a maximum of one hour delay.
803
The medical ethics committee of the Groningen University Medical Center Groningen 804 approved the study, and all subjects gave their written informed consent. 
Blood processing 910
Lithium Heparin-anticoagulated whole blood (500µl) was lysed using an ammonium 911 chloride-potassium solution (155mM ammonium chloride (NH4Cl), 10mM potassium 912 bicarbonate (KHCO3), 0,1mM EDTA). Cells were centrifuged for 5 min at 4°C, 550g after 913 which the cell pellet was washed twice with PBS containing 1% BSA, followed by staining 914 for cell surface markers.
916
Lung tissue processing 917
Bronchoscopy biopsy: A single cell solution was obtained by chopping the biopsies finely 918 using a single edge razor blade. The chopped tissue was then put in a mixture of 1mg/ml 919 collagenase D and 0.1mg/ml DNase I (Roche) in HBSS (Lonza). This was then placed at 920 37°C for 1hr with gentle agitation. The single cell suspension was forced through a 70µm 921 nylon cell strainer (Falcon). The suspension was centrifuged at 550g, 4°C for 5 min and 922 washed once with a PBS containing 1% BSA (Sigma Aldrich). The single cell suspensions 923 used for 10X Genomics scRNAseq analysis were cleared of red blood cells by using a Red 924 blood cell lysis buffer (eBioscience) followed by staining for cell surface markers.
926
Lung tissue resection: For each sample, 1-1.5 g of tissue was homogenized by mincing with 927 scissors into smaller pieces (~0.5 mm2/piece). Prior to tissue digestion, lung homogenates 928 were cleared from excessive blood by addition of 35 ml of ice-cold PBS, followed by gentle 929 shaking and tissue collection using a 40μm strainer. The bloody filtrate was discarded. The 930 tissue was transferred into 8 ml of enzyme mix consisting of dispase (50 caseinolytic U/ml), 931 collagenase (2 mg/ml), elastase (1 mg/ml), and DNase (30 µg/ml) for mild enzymatic 932 digestion for 1 hour at 37°C while shaking. Enzyme activity was inhibited by adding 5 ml of 933 PBS supplemented with 10% FCS. Dissociated cells in suspension were passed through a 934 70μm strainer and centrifuged at 300g for 5 minutes at 4°C. The cell pellet was resuspended 935 in 3 ml of red blood cell lysis buffer and incubated at room temperature for 2 minutes to lyse 936 remaining red blood cells. After incubation, 10 ml of PBS supplemented with 10% FCS was 937 added to the suspension and the mix was centrifuged at 300g for 5 minutes at 4°C. The cells 938 were taken up in 1 ml of PBS supplemented with 10% FCS, counted using a Neubauer 939 chamber and critically assessed for single cell separation. Dead cells were counted to 940 calculate the overall cell viability, which needed to be above 85% to continue with Drop-Seq. 941 250,000 cells were aliquoted in 2. 
